Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb
Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies,…
CertaraApril 18, 2024
The Challenges and Opportunities of Rare Disease Drug Development
This whitepaper by drug development experts reflect on some of these challenges and opportunities in…
CertaraApril 18, 2024
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraApril 16, 2024
Certara Announces New Corporate Headquarters
New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and…
CertaraApril 15, 2024
What are biosimilars & how are they developed?
Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies…
CertaraApril 15, 2024
Exploring ADC pharmacokinetics using QSP
The Pharmacokinetics (PK) of ADC therapeutics typically show a discrepancy between the PK of total…
CertaraApril 12, 2024
Enhancing Regulatory Writing: The Power of Style Guides
Learn more about our Document Quality Services TranscriptMany pharmaceutical industry professionals once considered standardizing regulatory writing style…
CertaraApril 12, 2024
Molecular Glue Drug Development Summit 2024 Recap
Lear more about Quantitative Systems Pharmacology Transcript: Hello, and welcome to Certara Talks. I'm Doctor…
CertaraApril 12, 2024
